Why Is Halma Plc Up Today?

Halma Plc (LSE:HLMA) shares rose 0.76% to 3,464.0p today, as investors reviewed one of the UK stock market's longest-running growth records. The safety, environmental and healthcare technology group recently reported its results for the year to 31 March 2026.

Halma delivered Revenue of £2,582.3m, up 15%, and adjusted EBIT of £594.5m, up 22%. Adjusted EPS rose 21% to 114.05p, and the adjusted EBIT Margin improved 140 basis points to 23.0%.

The share price gain is modest, and it comes alongside a Business that has increased its Dividend by at least 5% for 47 consecutive years. Industrial and technology groups with consistent Earnings records often attract attention when investors look for dependable growth in a changing economic backdrop.

About Halma Plc

Halma Plc is a UK-based group of life-saving technology businesses operating in safety, environmental and healthcare markets.

The group is organised around a decentralised model in which individual subsidiaries operate with a high degree of autonomy while benefiting from the group's financial discipline and Acquisition capability.

Its products include hazard detection, fire and gas safety, water analysis, environmental monitoring, optical technologies and medical devices.

Marc Ronchetti is Group Chief Executive and Carole Cran is Chief Financial Officer, and LSE:HLMA is widely followed as a quality industrial technology name.

Key Reasons Behind Today's Uptick

Today's 0.76% gain is best understood in the context of Halma's fundamentals and the wider stock market.

The company has reported record levels of reinvestment, double-digit organic growth and a margin that is rising, while its outlook for 2026/27 points to a further year of low double-digit organic revenue growth.

Investors also tend to value companies with long dividend and profit records during periods of uncertainty, since those records reflect resilient Demand for safety and monitoring technologies.

FY2025/26 Financial Performance

For the 12 months to 31 March 2026, Halma reported revenue of £2,582.3m, up 15% from £2,248.1m a year earlier. Organic revenue growth was 16%.

Adjusted EBIT increased 22% to £594.5m, with organic growth of 19%. The adjusted EBIT margin reached 23.0%.

Statutory profit before interest and tax rose 27% to £520.7m, while statutory EPS increased 26% to 98.57p.

Adjusted profit has now grown for 23 consecutive years, a record that sits at the heart of the group's reputation.

Returns and Cash Conversion

Halma's adjusted return on total invested Capital improved 120 basis points to 16.2%, toward the upper end of its 12% to 17% target range.

Adjusted cash conversion was 93%, ahead of the group's 90% target, although lower than the 112% reported the previous year.

Net Debt to adjusted EBITDA was 1.16 times, well within the group's operating range of up to 2 times, which leaves capacity for further acquisitions.

Dividend Record

Halma declared a total dividend of 24.74p for the year, up 7% from 23.12p. This comprises an Interim Dividend of 9.63p and a proposed final dividend of 15.11p.

It marks the 47th consecutive year in which the dividend has grown by 5% or more.

Such a record is rare among UK-listed companies and supports interest in LSE:HLMA from investors who value predictable Shareholder distributions.

Investment, R&D and Acquisitions

Halma reinvested more than £600m during the year, a record. This included R&D spending of £123m, up 13% and equal to 4.7% of revenue, and Capital Expenditure of £56m, up 24%.

The group completed five acquisitions for total consideration of £447m, and two more after the year end for about £75m.

It also completed one disposal during the year and two after the year end, which shows active Portfolio Management alongside acquisition activity.

Sustainable Growth Model

Halma's strategy is built around what it calls its Sustainable Growth Model. The model combines a decentralised structure, disciplined acquisitions and consistent reinvestment for growth.

The aim is to give each business the freedom to serve its markets while sharing expertise, capital and best practice across the group.

This approach allows Halma to enter niche markets with firm regulatory or safety demand, where customers value reliability and technical performance over price alone.

Photonics and Structural Growth Themes

Halma reported that photonics added about 8 percentage points to organic revenue growth in FY2025/26, and the group expects it to add about 5 percentage points in 2026/27.

Demand for sensing, imaging and optical technologies is linked to long-term themes such as healthcare diagnostics, data infrastructure and industrial automation.

Regulation covering workplace safety, clean water and environmental protection provides further structural support across the portfolio.

Outlook for 2026/27

For 2026/27, Halma expects low double-digit organic constant-currency revenue growth, including a photonics contribution of about 5 percentage points.

The adjusted EBIT margin is expected to be in line with FY2025/26 on a comparable basis.

Management also described an order book and order intake that are ahead of both revenue and the prior year.

Balance Sheet Capacity

Halma ended the year with net debt to adjusted EBITDA of 1.16 times, compared with 0.97 times a year earlier.

The increase reflects the record level of acquisition spending and reinvestment, and it still leaves substantial headroom below the top of the group's operating range of 2 times.

This flexibility allows Halma to continue acquiring niche businesses while maintaining its dividend progression.

Leadership and Operating Model

Group Chief Executive Marc Ronchetti leads a management team that oversees a portfolio of specialist subsidiaries across the world.

The decentralised operating model allows each Subsidiary to react quickly to customer needs, while the group provides capital, governance and strategic direction.

Consistency in this model has been central to 23 consecutive years of adjusted profit growth and the 47-year dividend record that LSE:HLMA investors follow closely.

Healthcare and Safety Demand Drivers

Healthcare technology benefits from ageing populations, demand for diagnostics and continued Investment in clinical equipment.

Safety technology is supported by regulation, insurance requirements and the need to protect people and Assets in industrial and public environments.

Environmental and analysis products serve water quality, emissions and monitoring needs, which are increasingly shaped by public policy.

Key Growth Catalysts

The first catalyst for LSE:HLMA is acquisition-led expansion, supported by a healthy Balance Sheet and a large pipeline of niche targets.

The second is continued demand across safety and environmental markets, where regulation and customer investment often grow regardless of the economic cycle.

A third is the contribution from higher-growth areas such as photonics and healthcare technology, where innovation can support margin expansion.

Industrial Sector and Economic Exposure

Halma operates internationally, so its performance is influenced by industrial activity, healthcare budgets, infrastructure spending and currency movements.

Its portfolio is diversified across many end markets, which helps to reduce reliance on any single customer or region.

Even so, a slowdown in global investment or changes in trade policy could affect order timing and growth rates.

Risks

Acquisition integration remains one of the most important risks for a group that grows partly through deals. Paying too much or failing to integrate a business could reduce returns.

Cash conversion fell to 93% from 112%, and investors will watch whether it remains above the 90% target as growth accelerates.

Currency swings, Supply chain pressures and the pace of customer spending on safety and monitoring technology could also affect results.

Finally, a share price that reflects Halma's long record leaves the company with a high bar to meet each year.

Conclusion

Halma Plc's 0.76% rise to 3,464.0p follows a year of 15% revenue growth, 22% growth in adjusted EBIT and a 7% increase in the dividend to 24.74p.

A record reinvestment programme, active acquisitions and a margin of 23.0% show a business that continues to expand its position in safety, environmental and healthcare technology.

The key factors to monitor are organic growth against the low double-digit outlook, margin delivery, cash conversion, acquisition performance and the extension of the group's long dividend record.